Neuphoria Therapeutics Inc.
NEUPNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $14.86M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.19$8.44
- Volume (live)
- -
- Avg. volume (3M)
- 19.68K
Neuphoria Therapeutics (NEUP) Stock Price & Financial Analysis
Neuphoria Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.37 - $3.42 |
|---|---|
| 52-Week High | $8.44 |
| 52-Week Low | $3.19 |
| Open | $3.42 |
| Volume (last close) | 26.70K |
| Average Volume (3M) | 19.68K |
| Revenue (TTM) | 1.17M |
|---|---|
| Net Income (TTM) | -18.53M |
| Free Cash Flow (TTM) | -12.35B |
| EPS (TTM) | −$4.21 |
| Profit Margin | -1578.40% |
| Operating Margin | -1187.73% |
| Return on Equity (ROE) | -75.34% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 14.86M |
|---|---|
| Shares Outstanding | 4.40M |
| Price to Sales (P/S) | 12.65 |
| Price to Book (P/B) | 0.60 |
| EV/EBITDA | 0.38 |
| 50-Day MA | $3.66 |
|---|---|
| 200-Day MA | $4.19 |
| 1-Year Change | −14.07% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Neuphoria Therapeutics at a Glance
As of the Oct 26, 2026 close, Neuphoria Therapeutics (NEUP) has a market capitalization of $14.86M. The stock trades at 12.7× sales. Over the trailing twelve months it lost $18.53M on revenue of $1.17M and burned $12.35B of free cash flow. Revenue fell 92.3% year over year.
As of its latest reported balance sheet, it holds $19.87M in cash and securities against $34.34K of debt, a net cash position of $19.83M.
Neuphoria Therapeutics does not currently pay a dividend.
The share price is down 14.1% over the past year. At $3.38 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $3.19 to $8.44, below its 200-day moving average of $4.19.
Frequently Asked Questions About Neuphoria Therapeutics
What is the current stock price for NEUP?
As of the Oct 26, 2026 close, NEUP stock trades at $3.38. The 52-week range is $3.19–$8.44, with a day range of $3.37–$3.42.
What is the P/E ratio for NEUP?
The P/E ratio (Price-to-Earnings) for NEUP is shown in the Key Statistics section. This valuation metric helps compare Neuphoria Therapeutics Inc. to industry peers.
Does NEUP pay dividends?
Neuphoria Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NEUP?
Analyst ratings and recommendations for NEUP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NEUP?
As of the Oct 26, 2026 close, Neuphoria Therapeutics's market capitalization is $14.9M, classifying it as a micro-cap company. Neuphoria Therapeutics operates in the Healthcare sector within the Biotechnology industry.